Loading organizations...
§ Venture Capital · Beijing, Beijing, China
Zhongguancun Kaiyuan Capital operates as an early-stage venture capital fund, strategically deploying capital into promising enterprises. The firm concentrates its investment activities primarily within the information technology and biomedicine sectors, targeting emerging companies that demonstrate significant growth potential and innovative solutions.
Established in May 2018, Zhongguancun Kaiyuan Capital is based in Beijing, China, functioning as part of the larger ZGC Group. The ZGC Group was initiated by the Beijing Municipal Government, providing Kaiyuan Capital with a foundation rooted in a strategic intent to bolster technological innovation and industrial upgrading within the region.
The firm's portfolio comprises early-stage ventures in high-tech fields, which receive financial backing and strategic guidance. Its vision aligns with supporting the growth of China's strategic emerging industries, aiming to cultivate enterprises that will drive future advancements across key technological domains.
Zhongguancun Kaiyuan Capital has 1 tracked investment across 1 company. The latest tracked deal is $40.0M Series B in Ranok Therapeutics in August 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 18, 2021 | Ranok Therapeutics | $40.0M Series B | Zhihua YU, Hong WEN | WU Capital |